Arrowhead Pharmaceuticals, Inc. (LON:0HI3)
London · Delayed Price · Currency is GBP · Price in USD 63.28
+1.66 (2.70%)
At close: Feb 13, 2026
Arrowhead Pharmaceuticals Market Cap
Arrowhead Pharmaceuticals has a market cap or net worth of 6.56 billion as of February 13, 2026. Its market cap has increased by 223.02% in one year.
Market Cap
6.56B
Enterprise Value
6.39B
Revenue
810.60M
Ranking
n/a
PE Ratio
43.63
Stock Price
63.28
Market Cap Chart
Since January 13, 2004, Arrowhead Pharmaceuticals's market cap has increased from 17.94M to 6.56B, an increase of 36,441.27%. That is a compound annual growth rate of 30.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 6.56B | -2.17% |
| Dec 31, 2025 | 6.70B | 258.70% |
| Dec 31, 2024 | 1.87B | -27.60% |
| Dec 29, 2023 | 2.58B | -27.67% |
| Dec 30, 2022 | 3.57B | -30.28% |
| Dec 31, 2021 | 5.12B | -11.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Genus | 2.03B |
| Oxford Nanopore Technologies | 1.31B |
| Oxford Biomedica | 994.46M |
| PureTech Health | 309.36M |
| Avacta Group | 253.69M |
| Scancell Holdings | 129.72M |
| Bioventix | 91.44M |
| 4basebio | 89.00M |